Algamed Therapeutics Overview
Algamed Therapeutics specializes in developing technologies dedicated to treating common vaginal conditions, such as dryness, vaginal infections (including yeast infections), menstrual cramps, dyspareunia, and hopefully endometriosis. The company's first product is Secret de Joie, a natural, hormone-free jelly for treating vaginal dryness. Secret de Joie is intended for breast and ovarian cancer survivors who must avoid taking hormones and women who are postmenopausal, breastfeeding, diabetic, taking birth control pills, and more. The product relieves the dryness that causes discomfort and interferes with intercourse and helps to restore the affected skin.
Cumulative Funding Raised Over Time ($)
$910KSep 2021
Latest News
growth-positive
Algamed Therapeutics is tapping into nature for a femtech solution
Israeli biotech startup Algamed Therapeutics is using algae to create a gel called Revive, which is designed to treat atrophic vaginitis (vaginal dryness). The gel, formulated and patented by Scientific Advisors Ronnie Klein and Dr. Tammy Meiron, contains natural ingredients and is suitable for women who cannot use hormonal treatments. Algamed has raised $1.76 million from crowdfunding and angel investors and plans to hold a larger fundraising round next year. The companys current valuation is $6.46 million. Algamed hopes to address the chronic problem of vaginal dryness and improve womens sexual health and relationships.
Customers
growth-positive
הזהב הירוק: סטארטאפ ישראלי פיתח טכנולוגיית אצות כדי להפחית דלקות אצל נשים
Israeli medical startup AlgaMed has developed a natural bioactive gel using innovative algae technology, aimed at helping millions of women suffering from dryness, inflammation, and infections. The company has several registered patents for its technology and is now preparing to break into the US and Canadian markets. The product is free of synthetic materials and is a natural solution for women who have not found satisfactory results with synthetic products. The company is now seeking investment and plans to expand its sales and global distribution. The market value of womens health is expected to reach $47 billion by 2027.
InvestmentExpand
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | $910K |
| Last funding | $910K |
| Stage | Seed |
| Rounds | 2 |
| Investors | 1 |
Team Members
2
Employees: 1-10
Web & Social Links
| Website | www.secretdejoie.co.il/ |
Locations
Rosh Pinna, Israel
Photos & Videos
No files yet
Algamed Therapeutics Business
Business models
B2C, B2B2C
Product stage
Released
Employees
1-10
Sector
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & DevelopmentTarget Customer
Commerce & RetailDistribution ChannelsDistributorConsumersDemographics & FamilyWomenCore Technology
BiologicalsMicroorganismsTags (8)
femtechwomen-healthalgaeanti-inflammatorywomendrug-developmentbiopharmaceuticalpain-reliefGeographic Markets
United StatesCanadaAlgamed Therapeutics Financials
$910K
Total funding
Undisclosed
Capital raised
$910K
Last funding
Seed
Funding stage
2
Total rounds
1
Investors
Cumulative Funding Raised Over Time ($)
$910KSep 2021
Private Equity Funding
Equity crowdfunding
Sep 2021
$910K
PipelBiz
Non-Equity Funding
GrantEvent
Undisclosed
Israel Innovation Authority
Algamed Therapeutics Lifecycle
Cumulative Funding Raised Over Time
$910KSep 2021
All Events
Equity crowdfunding
Sep 2021
$910K
PipelBiz
GrantEvent
Undisclosed
Israel Innovation Authority
Algamed Therapeutics News
2 articles
growth-positive
Algamed Therapeutics is tapping into nature for a femtech solution
Israeli biotech startup Algamed Therapeutics is using algae to create a gel called Revive, which is designed to treat atrophic vaginitis (vaginal dryness). The gel, formulated and patented by Scientific Advisors Ronnie Klein and Dr. Tammy Meiron, contains natural ingredients and is suitable for women who cannot use hormonal treatments. Algamed has raised $1.76 million from crowdfunding and angel investors and plans to hold a larger fundraising round next year. The companys current valuation is $6.46 million. Algamed hopes to address the chronic problem of vaginal dryness and improve womens sexual health and relationships.
Customers
growth-positive
הזהב הירוק: סטארטאפ ישראלי פיתח טכנולוגיית אצות כדי להפחית דלקות אצל נשים
Israeli medical startup AlgaMed has developed a natural bioactive gel using innovative algae technology, aimed at helping millions of women suffering from dryness, inflammation, and infections. The company has several registered patents for its technology and is now preparing to break into the US and Canadian markets. The product is free of synthetic materials and is a natural solution for women who have not found satisfactory results with synthetic products. The company is now seeking investment and plans to expand its sales and global distribution. The market value of womens health is expected to reach $47 billion by 2027.
InvestmentExpand
Algamed Therapeutics Team
Yale Dvory
CTO & Operations Manager
Employee Info
| Employees (range) | 1-10 |
| Exact count | 1 |
| Team members | 3 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 11 classification IDs that could be used for matching.
Algamed Therapeutics Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 90/100 |
| Missing | video or image, markets, not claimed |
| BI Verification | Yotam Maman |
| Registrar ID | 515114312 |
| Phone | +972723910444 |
| Creator | Yanina Wainscheinker |
| Creator email | yanina.wain@gmail.com |
| Last updater | Yanina Wainscheinker |
| Updater email | yanina.wainscheinker@sncentral.org |
| Last update | 2023-01-23T00:00:00.000Z |
| Created | 2021-09-13T00:00:00.000Z |
| Claimed | Yes |